10x Genomics, Inc. Operating Lease, Payments
10x Genomics, Inc. (TXG) reported Operating Lease, Payments of $16.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-02-13
- 10x Genomics, Inc. operating lease, payments for the quarter ending 2021-12-31 was $1.60M, a 20.00% decline year-over-year.
- 10x Genomics, Inc. operating lease, payments for the quarter ending 2021-09-30 was -$100.00K, a 105.00% decline year-over-year.
- 10x Genomics, Inc. operating lease, payments for the quarter ending 2021-06-30 was $2.20M, a 22.22% increase year-over-year.
- 10x Genomics, Inc. operating lease, payments for the quarter ending 2021-03-31 was $2.50M, a 92.31% increase year-over-year.
- 10x Genomics, Inc. operating lease, payments for fiscal 2025 was $16.20M, a 8.99% decline from fiscal 2024.
- 10x Genomics, Inc. operating lease, payments for fiscal 2024 was $17.80M, a 17.11% increase from fiscal 2023.
- 10x Genomics, Inc. operating lease, payments for fiscal 2023 was $15.20M, a 25.62% increase from fiscal 2022.
- 10x Genomics, Inc. operating lease, payments for fiscal 2022 was $12.10M, a 95.16% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $16.20M 10-K · filed 2026-02-13 | |||
| 2024-12-31 | $17.80M 10-K · filed 2026-02-13 | |||
| 2023-12-31 | $15.20M 10-K · filed 2026-02-13 | |||
| 2022-12-31 | $12.10M 10-K · filed 2025-02-13 | |||
| 2021-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $1.50M derived: sum of 2 quarters · filed 2024-02-15 | $3.70M derived: sum of 3 quarters · filed 2024-02-15 | $6.20M 10-K · filed 2024-02-15 |
| 2021-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $2.10M derived: sum of 2 quarters · filed 2021-11-05 | $4.60M 10-Q · filed 2021-11-05 | $6.60M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $4.70M 10-Q · filed 2021-08-06 | $6.70M derived: sum of 3 quarters · filed 2023-02-16 | $8.70M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $2.50M 10-Q · filed 2021-05-07 | $4.50M derived: sum of 2 quarters · filed 2023-02-16 | $6.50M derived: sum of 3 quarters · filed 2023-02-16 | $8.30M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $4.00M derived: sum of 2 quarters · filed 2023-02-16 | $5.80M derived: sum of 3 quarters · filed 2023-02-16 | $7.10M 10-K · filed 2023-02-16 |
| 2020-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $3.80M derived: sum of 2 quarters · filed 2021-11-05 | $5.10M 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $3.10M 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | $1.30M 10-Q · filed 2021-05-07 |